Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 46751-46800 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05510934
Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.
N/A
Recruiting
60 participants
Started: Sep 30, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05571033
Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy
NA
Recruiting
12 participants
Started: Sep 30, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05531604
Appetitive Conditioning in Anorexia Nervosa
N/A
Recruiting
90 participants
Started: Sep 30, 2022 · Completed: Jun 30, 2026
1 condition
5 sponsors
1 location
NCT05518305
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
N/A
Recruiting
250 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2027
4 conditions
6 sponsors
1 location
NCT05704153
Modelling and Control of Non-invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A)
NA
Recruiting
18 participants
Started: Sep 30, 2022 · Completed: Oct 31, 2024
3 conditions
5 sponsors
1 location
NCT05200559
T-regulatory Cell Depletion with E7777 Combined with Pembrolizumab in Recurrent or Metastatic Solid Tumors
PHASE1/PHASE2
Recruiting
70 participants
Started: Sep 30, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05246202
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
NA
Recruiting
250 participants
Started: Sep 30, 2022 · Completed: May 31, 2026
2 conditions
2 sponsors
1 location
NCT06578533
Keeping RAASi Treatment With Optimal Potassium Control
PHASE3
Recruiting
78 participants
Started: Sep 30, 2022 · Completed: Jul 30, 2026
1 condition
1 sponsor
5 locations
NCT05535933
HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
PHASE2/PHASE3
Recruiting
110 participants
Started: Sep 30, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
5 locations
NCT05565157
Flapless Zygomatic Implants Robot-assisted Placement
NA
Recruiting
15 participants
Started: Sep 30, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05496751
Response Variability to Exercise
NA
Recruiting
200 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT05775874
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
PHASE2
Recruiting
80 participants
Started: Sep 30, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05566574
A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
PHASE1/PHASE2
Recruiting
84 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2025
2 conditions
2 sponsors
7 locations
NCT05557552
Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer
NA
Recruiting
56 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT05505604
PENG vs FICB for Hip Fracture in ED Patients
NA
Recruiting
50 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT05479006
Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments
NA
Recruiting
30 participants
Started: Sep 30, 2022 · Completed: Jan 30, 2026
1 condition
2 sponsors
1 location
NCT05284643
Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
NA
Recruiting
96 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2029
1 condition
1 sponsor
1 location
NCT04631042
Developing Brain, Impulsivity and Compulsivity
N/A
Recruiting
1,100 participants
Started: Sep 30, 2022 · Completed: Dec 31, 2031
5 conditions
1 sponsor
1 location
NCT05556759
Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty
NA
Recruiting
72 participants
Started: Sep 30, 2022 · Completed: Nov 1, 2025
1 condition
1 sponsor
1 location
NCT05649007
Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery
N/A
Recruiting
630 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2036
1 condition
1 sponsor
1 location
NCT05543330
A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC
PHASE1/PHASE2
Recruiting
96 participants
Started: Sep 30, 2022 · Completed: Oct 15, 2026
2 conditions
1 sponsor
1 location
NCT05443126
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
PHASE1/PHASE2
Recruiting
265 participants
Started: Sep 30, 2022 · Completed: Jun 30, 2027
2 conditions
1 sponsor
36 locations
NCT05744466
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
N/A
Recruiting
1,500 participants
Started: Sep 30, 2022 · Completed: Dec 10, 2027
1 condition
1 sponsor
1 location
NCT05568420
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
N/A
Recruiting
160 participants
Started: Sep 30, 2022 · Completed: Sep 30, 2026
1 condition
3 sponsors
1 location
NCT05414409
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
PHASE2
Recruiting
114 participants
Started: Sep 30, 2022 · Completed: Nov 2, 2026
2 conditions
2 sponsors
1 location
NCT05559008
A Umbrella Study in R/R PTCL Guided by Molecular Subtypes
PHASE1/PHASE2
Recruiting
116 participants
Started: Sep 30, 2022 · Completed: Jan 26, 2026
1 condition
1 sponsor
1 location
NCT05432479
Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief
NA
Recruiting
80 participants
Started: Sep 30, 2022 · Completed: May 31, 2026
1 condition
3 sponsors
2 locations
NCT05823701
Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients
PHASE2
Recruiting
23 participants
Started: Sep 30, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05000528
Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia
NA
Recruiting
44 participants
Started: Sep 30, 2022 · Completed: Sep 29, 2025
1 condition
1 sponsor
1 location
NCT05523128
The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.
NA
Recruiting
6 participants
Started: Sep 29, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05556473
F-Tryptophan PET/CT in Human Cancers
PHASE1
Recruiting
24 participants
Started: Sep 29, 2022 · Completed: Dec 31, 2026
5 conditions
2 sponsors
1 location
NCT05525962
Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolescents in Child Welfare System.
N/A
Recruiting
300 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2027
8 conditions
1 sponsor
5 locations
NCT05084248
Vitamin D Deficiency in Adults Following a Major Burn Injury
PHASE4
Recruiting
70 participants
Started: Sep 29, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06315686
The Dynamic Monitoring of Cerebrospinal Fluid ctDNA
PHASE2
Recruiting
20 participants
Started: Sep 29, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05067764
Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease
NA
Recruiting
172 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2029
1 condition
1 sponsor
2 locations
NCT05564689
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
N/A
Recruiting
60 participants
Started: Sep 29, 2022 · Completed: Sep 30, 2026
4 conditions
1 sponsor
1 location
NCT05734222
Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias
NA
Recruiting
110 participants
Started: Sep 29, 2022 · Completed: May 23, 2025
3 conditions
1 sponsor
1 location
NCT05424263
Acetate and Age-associated Arterial Dysfunction
PHASE2
Recruiting
66 participants
Started: Sep 29, 2022 · Completed: Sep 1, 2025
3 conditions
1 sponsor
1 location
NCT05521412
EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T
PHASE1/PHASE2
Recruiting
42 participants
Started: Sep 29, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05574244
Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction
NA
Recruiting
336 participants
Started: Sep 29, 2022 · Completed: Mar 31, 2029
1 condition
1 sponsor
18 locations
NCT04169451
IUI With Letrozole Versus in Natural Cycle
NA
Recruiting
982 participants
Started: Sep 29, 2022 · Completed: Jun 30, 2026
2 conditions
5 sponsors
1 location
NCT05909800
Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.
PHASE2
Recruiting
102 participants
Started: Sep 29, 2022 · Completed: Jul 31, 2024
1 condition
2 sponsors
2 locations
NCT05543993
COVID Booster in Pregnancy and Lactation
N/A
Recruiting
200 participants
Started: Sep 29, 2022 · Completed: Mar 1, 2025
1 condition
3 sponsors
1 location
NCT05771168
Surgery for Male Stress Urinary Incontinence
N/A
Recruiting
138 participants
Started: Sep 29, 2022 · Completed: Sep 29, 2027
1 condition
1 sponsor
1 location
NCT05414344
A Brief Intervention for Alcohol Users With Interpersonal Trauma
NA
Recruiting
225 participants
Started: Sep 29, 2022 · Completed: Apr 30, 2026
4 conditions
1 sponsor
1 location
NCT05219110
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
NA
Recruiting
1,040 participants
Started: Sep 29, 2022 · Completed: Aug 31, 2027
2 conditions
27 sponsors
26 locations
NCT05421143
Co-design of a Seamless Person-centered Intervention to Optimize Medication Use Across Healthcare Levels
N/A
Recruiting
240 participants
Started: Sep 29, 2022 · Completed: Apr 30, 2027
1 condition
3 sponsors
1 location
NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
PHASE3
Recruiting
409 participants
Started: Sep 29, 2022 · Completed: Sep 30, 2031
2 conditions
4 sponsors
42 locations
NCT05564078
IL-13 Blockade and Airway Autoimmunity in Asthma
N/A
Recruiting
50 participants
Started: Sep 28, 2022 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05382169
Prevalence of Mast Cell Activation Syndrome in Patients With EDS With Digestive Disorders
N/A
Recruiting
30 participants
Started: Sep 28, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
933
934
935
936
937
938
939
More pages
1333
Next